Labetuzumab is a humanized anti-carcinoembryonic antigen (CEA) monoclonal antibody with anticancer activity that inhibits tumor growth and is used in the study of thyroid and colorectal cancer (CRC).
Molecular Weight:
145.1 kDa
Purity:
95.60%
CAS Number:
[219649-07-7]
Target:
Others
T9901A-004
* VAT and and shipping costs not included. Errors and price changes excepted